During the past decade, Clinical Neuroscience Solutions, Inc. conducted 112 clinical trials. In the 10-year time frame, 112 clinical trials started and 93 clinical trials were completed, i.e. on average, 83% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 57 clinical trials were completed. i.e. 132.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Neuroscience Solutions, Inc." #1 sponsor was "Pfizer" with 23 trials, followed by "Shire" with 21 trials sponsored, "Sunovion" with 14 trials sponsored, "Eli Lilly and Company" with 10 trials sponsored and "Allergan" with 10 trials sponsored. Other sponsors include 91 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Neuroscience Solutions, Inc." #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Premier Research Group plc" with 2 trials as a collaborator and "Purdue Pharma LP" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Neuroscience Solutions, Inc." are "Major Depressive Disorder" (24 trials), "ADHD" (11 trials), "Depressive Disorder, Major" (9 trials), "Migraine" (9 trials) and "Attention Deficit Hyperactivity Disorder (ADHD)" (7 trials). Many other conditions were trialed in "Clinical Neuroscience Solutions, Inc." in a lesser frequency.

Most popular intervention types in "Clinical Neuroscience Solutions, Inc." are "Drug" (165 trials), "Other" (11 trials), "Biological" (8 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (102 trials), "Dasotraline" (6 trials), "placebo" (5 trials), "Atogepant" (4 trials) and "Galcanezumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Neuroscience Solutions, Inc." are 167 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Neuroscience Solutions, Inc.". undefined are not yet recruiting, 16 are recruiting, 5 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 130 completed trials in Clinical Neuroscience Solutions, Inc., undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Neuroscience Solutions, Inc., 1 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 108 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 1 trials that are defined as “Not Applicable".